Health Care: Drugs

Keryx Biopharmaceuticals Inc. (KERX: NASDAQ)

$8.03 0.00 | 0.00%
05/24/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 0.00 5.00M 0.00 25.19M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 5.00M 0.00 25.19M
Selling, General, and Administrative Expenses 7.71M 6.74M 6.25M 6.77M
Research & Development 19.37M 27.01M 14.96M 8.60M
Operating Income before D & A (EBITDA) -27.08M -28.75M -21.22M 9.82M
Depreciation & Amortization 35.00K 47.00K 60.00K 92.00K
Interest Income 52.00K 159.00K 148.00K 315.00K
Other Income - Net 1.67M 221.00K 616.00K 352.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -25.40M -28.42M -20.51M 10.39M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -25.40M -28.42M -20.51M 10.39M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -25.36M -28.37M -20.45M 10.48M
Net Income From Discontinued Operations 0.00 246.00K 120.00K 0.00
Net Income From Total Operations -25.36M -28.12M -20.33M 10.48M
Extraordinary Income/Losses 2.64M 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -22.72M -28.12M -20.33M 10.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -25.36M -28.37M -20.45M 10.48M
Preferred Dividends
Net Income Available To Common -25.36M -28.37M -20.45M 10.48M
Basic EPS from Continuing Ops. -0.36 -0.42 -0.34 0.21
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.36 -0.42 -0.34 0.21
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.04 0.00 0.00 0.00
Basic EPS, Total -0.32 -0.42 -0.34 0.21
Basic Normalized Net Income/Share -0.36 -0.42 -0.34 0.21
EPS fr Continuing Ops. -0.32 -0.42 -0.34 0.21
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.32 -0.42 -0.34 0.21
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.32 -0.42 -0.34 0.21
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.32 -0.42 -0.34 0.21
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with KERX

View All

Latest KERX Headlines from TheStreet

More Financial News for KERX

Press Releases for KERX

See All Press Releases

Partner Headlines for KERX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter